POLE2 and breast cancer: An AATT deletion in intron 18 of the POLE2 subunit of Polymerase ε is associated with breast cancer, and POLE2 is suggested to contribute to lapatinib resistance in HER2+ breast cancer patients with acquired lapatinib resistance [99,100].